Pfizer Stock In The News

PFE Stock  USD 43.80  0.00  0.00%   
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Pfizer and other traded companies coverage. We help investors stay connected with Pfizer headlines for the 31st of January to make an informed investment decision based on correlating the impacts of news items on Pfizer Stock performance. Please note that trading solely based on the Pfizer Inc hype is not for everyone as timely availability and quick action are needed to avoid losses. As of January 31, 2023, Net Income Common Stock is expected to decline to about 17 B.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Pfizer headlines in addition to utilizing other, more conventional financial analysis modules. Please check Pfizer Backtesting and Pfizer Hype Analysis.

Pfizer Today Top News and Investor Outlook

reuters
India's 2022 gold consumption drops 3% as prices rally - WGC
www.reuters.com
 Bullish
news
UBS investment bank profit drops 30% on dealmaking slide
www.fnlondon.com
 Neutral
cnbc News
Nearly a year on from the supposed Russian exodus, most major companies have yet to withdraw
www.cnbc.com
 Neutral
Cointelegraph News at Macroaxis
Crypto firms cut nearly 3,000 jobs in January despite Bitcoin's rise
cointelegraph.com
 Bearish
Macroaxis News: business-standard.com
Online marketplace OLX to slash over 1,500 jobs globally, including India
www.business-standard.com
 Bearish
Macroaxis News: apnews.com
Boeing bids farewell to an icon, delivers last 747 jumbo jet
apnews.com
 Neutral
Macroaxis News: globenewswire.com
Standard Lithium Installs Carbon Capture Pilot Plant, Testing Novel Technology to Limit Emissions and Advance Sustainability
www.globenewswire.com
 Bullish
news
Rock Tech Lithium: Positive Assay Results of Summer Exploration Program and Three New Prospects at Georgia Lake
www.newswire.ca
 Bullish
news
Troubled Kaisa aims to resume shares trading in March after delayed audit
www.scmp.com
 Neutral
news
IMF says recession "not in our baseline" as it raises global growth forecasts
www.axios.com
 Neutral
Macroaxis News: moneycontrol.com
Adani drops off list of world's top 10 richest people
www.moneycontrol.com
 Bullish
benzinga news
China Offers Free Trade Zone With Gulf Amid US-Saudi Rift
www.benzinga.com
 Bullish
CNN News
Live updates: Russia's war in Ukraine
www.cnn.com
 Neutral
Usa forbes News
Greggs Is Taking The Humble Sausage Roll To New Heights With Seventh Airport Store
www.forbes.com
 Neutral
prnewswire News
Bain & Company's Global M&A Report sees opportunity for bold moves in an uncertain 2023 market
www.prnewswire.com
 Bullish
marketwatch News
What the Eagles-Chiefs Super Bowl matchup can tell us about the stock market
www.marketwatch.com
 Bullish
Barrons News
AMD's Earnings Should Show Impact of Weak PC Demand
www.barrons.com
 Bearish
Macroaxis News: ft.com
Renault and Nissan reach a deal to save alliance
www.ft.com
 Neutral

Pfizer Inc Past News Timeline

Pfizer's linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Pfizer Inc investors visualize upcoming and past events in order to time the market based on Pfizer Inc noise-free hype analysis.
Pfizer stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Pfizer earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Pfizer that are available to investors today. That information is available publicly through Pfizer media outlets and privately through word of mouth or via Pfizer internal channels. However, regardless of the origin, that massive amount of Pfizer data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Pfizer news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Pfizer relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Pfizer's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Pfizer alpha.

Pfizer Largest EPS Surprises

Earnings surprises can significantly impact Pfizer's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
1999-07-19
1999-06-300.170.190.0211 
1998-10-13
1998-09-300.190.17-0.0210 
1998-07-09
1998-06-300.150.170.0213 
2000-04-18
2000-03-310.250.280.0312 
2009-04-28
2009-03-310.490.540.0510 
2008-01-23
2007-12-310.470.520.0510 
View All Earnings Estimates

Pfizer Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Pfizer Inc Stock. Current markets are strongly bearish. About 78% of major world exchanges and indexes are down. See today's market update for more information.
news
30th of January 2023
Pantera is finding more of that lovely manganese at Weelarrana
at stockhead.com.au 
reuters
27th of January 2023
Omicron sub-variant XBB.1.5 accounts for 61.3 percent of U.S. COVID cases - CDC
at reuters.com 

Pfizer Investors Sentiment

The influence of Pfizer's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Pfizer. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.
Investor biases related to Pfizer's public news can be used to forecast risks associated with investment in Pfizer. The trend in average sentiment can be used to explain how an investor holding Pfizer can time the market purely based on public headlines and social activities around Pfizer Inc. Please note that most equiteis that are difficult to arbitrage are affected by market sentiment the most.
Pfizer's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Pfizer's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Pfizer's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Pfizer.

Pfizer Implied Volatility

    
  58.37  
Pfizer's implied volatility exposes the market's sentiment of Pfizer Inc stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Pfizer's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Pfizer stock will not fluctuate a lot when Pfizer's options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Pfizer in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Pfizer's short interest history, or implied volatility extrapolated from Pfizer options trading.
Please check Pfizer Backtesting and Pfizer Hype Analysis. Note that the Pfizer Inc information on this page should be used as a complementary analysis to other Pfizer's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for Pfizer Stock analysis

When running Pfizer Inc price analysis, check to measure Pfizer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pfizer is operating at the current time. Most of Pfizer's value examination focuses on studying past and present price action to predict the probability of Pfizer's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Pfizer's price. Additionally, you may evaluate how the addition of Pfizer to your portfolios can decrease your overall portfolio volatility.
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Transaction History
View history of all your transactions and understand their impact on performance
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Is Pfizer's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pfizer. If investors know Pfizer will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pfizer listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.055
Market Capitalization
245.8 B
Quarterly Revenue Growth
(0.06) 
Return On Assets
0.1332
Return On Equity
0.3551
The market value of Pfizer Inc is measured differently than its book value, which is the value of Pfizer that is recorded on the company's balance sheet. Investors also form their own opinion of Pfizer's value that differs from its market value or its book value, called intrinsic value, which is Pfizer's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pfizer's market value can be influenced by many factors that don't directly affect Pfizer's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pfizer's value and its price as these two are different measures arrived at by different means. Investors typically determine Pfizer value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pfizer's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.